Cargando…
Nottingham Prognostic Index Plus (NPI+): a modern clinical decision making tool in breast cancer
BACKGROUND: Current management of breast cancer (BC) relies on risk stratification based on well-defined clinicopathologic factors. Global gene expression profiling studies have demonstrated that BC comprises distinct molecular classes with clinical relevance. In this study, we hypothesised that mol...
Autores principales: | Rakha, E A, Soria, D, Green, A R, Lemetre, C, Powe, D G, Nolan, C C, Garibaldi, J M, Ball, G, Ellis, I O |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3974073/ https://www.ncbi.nlm.nih.gov/pubmed/24619074 http://dx.doi.org/10.1038/bjc.2014.120 |
Ejemplares similares
-
Nottingham prognostic index plus (NPI+) predicts risk of distant metastases in primary breast cancer
por: Green, Andrew R., et al.
Publicado: (2016) -
Nottingham Prognostic Index Plus: Validation of a clinical decision making tool in breast cancer in an independent series
por: Green, Andrew R, et al.
Publicado: (2016) -
Identification of key clinical phenotypes of breast cancer using a reduced panel of protein biomarkers
por: Green, A R, et al.
Publicado: (2013) -
Identification and definition of novel clinical phenotypes of breast cancer through consensus derived from automated clustering methods
por: Green, AR, et al.
Publicado: (2008) -
The Practicability of a Novel Prognostic Index (PI) Model and Comparison with Nottingham Prognostic Index (NPI) in Stage I–III Breast Cancer Patients Undergoing Surgical Treatment
por: Wen, Jiahuai, et al.
Publicado: (2015)